# Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity

> **NCT01180231** · PHASE4 · UNKNOWN · sponsor: **Baker Heart and Diabetes Institute** · enrollment: 77 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** Moxonidine (Physiotens)
- **OTHER:** Dietary intervention

## Key facts

- **NCT ID:** NCT01180231
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2013-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01180231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01180231, "Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01180231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*